Allogene Therapeutics, Inc.ALLONASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
18.73%
↑ 100% above average
Average (31q)
-4214.69%
Historical baseline
Range
High:67.76%
Low:-129750.00%
Volatility
-3080.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 18.73% |
| Q2 2025 | 14.72% |
| Q1 2025 | 0.34% |
| Q4 2024 | 9.58% |
| Q3 2024 | 0.10% |
| Q2 2024 | -2.09% |
| Q1 2024 | 27.18% |
| Q4 2023 | -43.30% |
| Q3 2023 | 21.39% |
| Q2 2023 | 20.74% |
| Q1 2023 | -5.40% |
| Q4 2022 | -14.07% |
| Q3 2022 | -11.18% |
| Q2 2022 | 6.34% |
| Q1 2022 | -6.65% |
| Q4 2021 | 4.24% |
| Q3 2021 | -10.22% |
| Q2 2021 | -114.86% |
| Q1 2021 | 51.85% |
| Q4 2020 | -3.58% |
| Q3 2020 | -8.57% |
| Q2 2020 | -11.92% |
| Q1 2020 | 10.73% |
| Q4 2019 | -20.29% |
| Q3 2019 | -23.01% |
| Q2 2019 | -30.57% |
| Q1 2019 | -3.53% |
| Q4 2018 | 29.86% |
| Q3 2018 | 67.76% |
| Q2 2018 | -5094.53% |
| Q1 2018 | -129750.00% |
| Q4 2017 | 0.00% |